Apollon Formularies PLC APOL.AQ Stock
0.03 GBP
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
United Kingdom
Exchange
Aquis AQSE
Market Cap
224.51K GBP
LOW - HIGH [24H]
0.03
-
0.03 GBP
VOLUME [24H]
267K GBP
{{ volume }}
P/E Ratio
0
Earnings per share
0 GBP
Apollon Formularies PLC Price Chart
Apollon Formularies PLC APOL.AQ Financial and Trading Overview
| Apollon Formularies PLC stock price | 0.03 GBP |
| Previous Close | 0.14 GBP |
| Open | 0.14 GBP |
| Bid | 0.1 GBP x N/A |
| Ask | 0.22 GBP x N/A |
| Day's Range | 0.14 - 0.14 GBP |
| 52 Week Range | 0.0016 - 0.14 GBP |
| Volume | 500K GBP |
| Avg. Volume | 0 GBP |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
APOL.AQ Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Apollon Formularies PLC Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.14 GBP |
| 52 Week Low | 0.0016 GBP |
| 50-Day Moving Average | 0.001769 GBP |
| 200-Day Moving Average | 0.00593025 GBP |
APOL.AQ Share Statistics
| Avg. Volume (3 month) | 0 GBP |
| Avg. Daily Volume (10-Days) | 0 GBP |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Apollon Formularies PLC Stock
What is a current APOL.AQ stock price?
Apollon Formularies PLC APOL.AQ stock price today per share is 0.03 GBP.
How to purchase Apollon Formularies PLC stock?
You can buy APOL.AQ shares on the Aquis AQSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Apollon Formularies PLC?
The stock symbol or ticker of Apollon Formularies PLC is APOL.AQ.
How many shares does Apollon Formularies PLC have in circulation?
The max supply of Apollon Formularies PLC shares is 7.48M.
What is Apollon Formularies PLC Price to Earnings Ratio (PE Ratio)?
Apollon Formularies PLC PE Ratio is now.
What was Apollon Formularies PLC earnings per share over the trailing 12 months (TTM)?
Apollon Formularies PLC EPS is 0 GBP over the trailing 12 months.